Quantgene and Vikor Scientific Partner to Launch Serenity™ — Ground-Breaking Advancement in Precision Genomics, Personalized Medicine

Cision PR Newswire
February 17, 2021

Vikor Scientific, a leading, molecular diagnostics company with a rapidly expanding nationwide footprint, has announced a strategic investment in California-based Quantgene Inc. to accelerate the commercialization of Quantgene’s flagship product, Serenity™Serenity provides world-leading accuracy in precision genomics and AI-enabled personalized preventative care. The announcement was unveiled at SCBIO 2021South Carolina’s life sciences industry annual conference.

Read the full release, HERE.

Back To The Top